🔥 Popular | Latest

The Food and Drug Administration approved the first generic version of EpiPen, which is an epinephrine auto-injector used to treat life-threatening allergic reactions to such things as peanuts and bee stings in adult and children. ___ The generic version of the EpiPen is made by Teva Pharmaceuticals USA, and can now enter the market in competition with Mylan, the owners of the original EpiPen. Mylan is often under criticism for injection shortages as well as raising the price of its device from $100 to $600 for a set of two injections. ___ Scott Gottlieb, the commissioner of the F.D.A., commented on the release of the generic EpiPen: - “This approval means patients living with severe allergies who require constant access to lifesaving epinephrine should have a lower-cost option, as well as another approved product to help protect against potential drug shortages.” ___ The Food Allergy Research & Education advocacy group reports that roughly 15 million Americans, including six million children, have food allergies. Of these 6 million, potentially 2.4 million children have had a life-threatening incident.: HEALTH FIRST GENERIC EPIPEN Aug 17 | The F.D.A approves the first generic version of EpiPen, which can help lower the cost of a lifesaving product known for its high price point. The Food and Drug Administration approved the first generic version of EpiPen, which is an epinephrine auto-injector used to treat life-threatening allergic reactions to such things as peanuts and bee stings in adult and children. ___ The generic version of the EpiPen is made by Teva Pharmaceuticals USA, and can now enter the market in competition with Mylan, the owners of the original EpiPen. Mylan is often under criticism for injection shortages as well as raising the price of its device from $100 to $600 for a set of two injections. ___ Scott Gottlieb, the commissioner of the F.D.A., commented on the release of the generic EpiPen: - “This approval means patients living with severe allergies who require constant access to lifesaving epinephrine should have a lower-cost option, as well as another approved product to help protect against potential drug shortages.” ___ The Food Allergy Research & Education advocacy group reports that roughly 15 million Americans, including six million children, have food allergies. Of these 6 million, potentially 2.4 million children have had a life-threatening incident.

The Food and Drug Administration approved the first generic version of EpiPen, which is an epinephrine auto-injector used to treat life-t...

Save